Cargando…
Allosteric Site of ACE-2 as a Drug Target for COVID-19
[Image: see text] The coronavirus disease 2019 (COVID-19) pandemic has a significant impact on healthcare systems and our lives. Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provide protection against SARS-CoV-2. However, mutations in the viral genome are common, rai...
Autor principal: | Dutta, Kunal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864771/ https://www.ncbi.nlm.nih.gov/pubmed/35295933 http://dx.doi.org/10.1021/acsptsci.2c00003 |
Ejemplares similares
-
ACE2, a drug target for COVID-19 treatment?
por: Liu, Yang, et al.
Publicado: (2022) -
SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets
por: Raghuvamsi, Palur V, et al.
Publicado: (2021) -
Reversing allosteric communication: From detecting allosteric sites to inducing and tuning targeted allosteric response
por: Tee, Wei-Ven, et al.
Publicado: (2018) -
2013 Philip S. Portoghese
Medicinal Chemistry Lectureship:
Drug Discovery Targeting Allosteric Sites
por: Lindsley, Craig W.
Publicado: (2014) -
Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance
por: Maity, Swastika, et al.
Publicado: (2020)